药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Cariprazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cariprazine.
Potassium cation
Gantacurium
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gantacurium.
Potassium cation
BL-1020
The risk or severity of adverse effects can be increased when Cannabidiol is combined with BL-1020.
Potassium cation
PRX-08066
The risk or severity of adverse effects can be increased when Cannabidiol is combined with PRX-08066.
Potassium cation
Naluzotan
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Naluzotan.
Potassium cation
Naronapride
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Naronapride.
Potassium cation
Brivaracetam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brivaracetam.
Potassium cation
Pimavanserin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pimavanserin.
Potassium cation
Methsuximide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methsuximide.
Potassium cation
Tetrodotoxin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tetrodotoxin.
Potassium cation
APD791
The risk or severity of adverse effects can be increased when Cannabidiol is combined with APD791.
Potassium cation
Ezogabine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ezogabine.
Potassium cation
Iloperidone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iloperidone.
Potassium cation
Renzapride
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Renzapride.
Potassium cation
Pagoclone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pagoclone.
Potassium cation
Milnacipran
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Milnacipran.
Potassium cation
Bifeprunox
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bifeprunox.
Potassium cation
Cilansetron
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cilansetron.
Potassium cation
Dapoxetine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dapoxetine.
Potassium cation
Osanetant
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Osanetant.